Literature DB >> 22454919

The influence of elevated plasma hydrocortisone concentrations on antipyrine metabolism in man.

R J Flanagan1, A Richens.   

Abstract

1 The plasma half-life of antipyrine was estimated overnight in four healthy volunteers on two separate occasions, one during i.v. infusion of hydrocortisone (3 mg/h) and the second during an infusion of normal saline. 2 The plasma fluorogenic corticosteroid concentration averaged 12.5 μg/100 ml during saline infusion, increasing to 20.1 μg/100 ml during hydrocortisone infusion. 3 The mean antipyrine half-life increased from 9.7 h during saline infusion to 12.6 h during hydrocortisone infusion. 4 No consistent change was found in the apparent volume of distribution or urinary excretion of antipyrine, or of the urinary excretion of D-glucaric acid. 5 The stimulation by hydrocortisone of antipyrine metabolism demonstrated by other workers has not been found.

Entities:  

Year:  1974        PMID: 22454919      PMCID: PMC1402461          DOI: 10.1111/j.1365-2125.1974.tb00278.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  10 in total

1.  Biotransformation of prednisone by "trained" blocked and "untrained" liver enzymes.

Authors:  F G SULMAN; N KHAZAN; J E STEINER
Journal:  Arch Int Pharmacodyn Ther       Date:  1959-10-01

2.  [Acceleration of evipan degradation by glycocorticoids].

Authors:  H REMMER
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1958

3.  A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma.

Authors:  D MATTINGLY
Journal:  J Clin Pathol       Date:  1962-07       Impact factor: 3.411

Review 4.  Circadian rhythms of drug effectiveness and toxicity.

Authors:  M C Ede
Journal:  Clin Pharmacol Ther       Date:  1973 Nov-Dec       Impact factor: 6.875

5.  Urinary D-glucaric-acid excretion as a test for hepatic enzyme induction in man.

Authors:  J Hunter; J D Maxwell; M Carrella; D A Stewart; R Williams
Journal:  Lancet       Date:  1971-03-20       Impact factor: 79.321

6.  Effects of steroid hormones on drug-metabolizing enzyme systems in liver microsomes.

Authors:  F Wada; H Shimakawa; M Takasugi; T Kotake; Y Sakamoto
Journal:  J Biochem       Date:  1968-07       Impact factor: 3.387

7.  Biochemical studies on glucuronic acid and glucaric acid. 1. Quantitative chemical determination of D-glucaric acid in urine.

Authors:  M Ishidate; M Matsui; M Okada
Journal:  Anal Biochem       Date:  1965-05       Impact factor: 3.365

8.  Immediate decrease by hydrocortisone of the plasma half-life of antipyrine.

Authors:  A Breckenridge; C W Burke; D S Davies; M L Orme
Journal:  Br J Pharmacol       Date:  1973-02       Impact factor: 8.739

9.  Inhibition of drug metabolism. V. Inhibition of drug metabolism by steroids.

Authors:  T R Tephly; G J Mannering
Journal:  Mol Pharmacol       Date:  1968-01       Impact factor: 4.436

10.  Metabolism of exogenous cortisol in humans. I. Diurnal variation in plasma disappearance rate.

Authors:  P L Morselli; V Marc; S Garattini; M Zaccala
Journal:  Biochem Pharmacol       Date:  1970-05       Impact factor: 5.858

  10 in total
  6 in total

Review 1.  Drug pharmacokinetics in the postoperative period.

Authors:  J Elfstrom
Journal:  Clin Pharmacokinet       Date:  1979 Jan-Feb       Impact factor: 6.447

2.  Influence of prednisolone on antipyrine elimination in patients with obstructive lung disease.

Authors:  S Loft; K Simonsen; T Evald; H R Christensen; J Sonne; M Døssing
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 3.  Clinical pharmacokinetics and endocrine disorders. Therapeutic implications.

Authors:  P O'Connor; J Feely
Journal:  Clin Pharmacokinet       Date:  1987-12       Impact factor: 6.447

4.  Effect of halothane anaesthesia on salivary elimination of paracetamol.

Authors:  K Ray; C Adithan; J S Bapna; G L Kamatchi; K Ray; R B Mehta
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

5.  Urinary excretion of D-glucaric acid, an indicator of drug metabolizing enzyme activity, in patients with impaired renal function.

Authors:  D Kampf; I Roots; A G Hildebrandt
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

6.  Metabolism of phenazone in man after hydrocortisone administration.

Authors:  J Elfström; S Lindgren
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.